Theravance Biopharma
improvements in plasma were seen in patients with | Theravance Biopharma
Company
Deck Type
Sector
Industry
Deck date
November 2022
Slide
13 of 44
Related slides by other companies
Kymera
Results
December 2022
in inhibition of disease relevant plasma and acute phase reactants by in patients | Kymera
DICE Therapeutics
Investor Presentation
March 2023
visual improvements in psoriasis in days day dice | DICE Therapeutics
Oculis
Investor Presentation
July 2023
of patients with line improvement in at week | Oculis
Oculis
Results
May 2023
of patients with line improvement in at week vision gainers analysis at week | Oculis
Other recent decks by Theravance Biopharma
See all presentations (5 decks)
Results
August 2023
Results
May 2023
Investor Conference
April 2023
Results
February 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights